Every 424B that Joby Aviation, Inc. (JOBY) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow JOBY and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full JOBY filings page.
Joby Aviation, Inc. (JOBY) is registering up to 2,419,801 shares of common stock for resale by a selling stockholder. The shares are owned by Strata Critical, Inc. and were issued as stock consideration tied to EBITDA milestones under an August 2025 Equity Purchase Agreement related to acquiring a passenger segment from Strata Critical Medical.
Joby is not selling any shares in this transaction and will receive no cash proceeds; the selling stockholder will bear selling commissions while Joby covers registration expenses. As context, shares outstanding were 996,294,246 as of September 8, 2026. The supplement highlights potential future dilution from planned or possible issuances, including up to 49,701,789 shares in a second tranche under a Toyota purchase agreement at $5.03 per share, additional stock that may be used to satisfy a remaining $27.5 million purchase price under the same Equity Purchase Agreement, stock consideration under a $500.0 million Resonant Sciences acquisition (with about $50.0 million expected in JOBY shares at $7.4752 per share), a $750.0 million at-the-market equity distribution program, and 0.75% convertible senior notes due 2032.
Joby Aviation, Inc. is launching an “at the market offering” program to sell up to $750.0 million of common stock through Morgan Stanley, J.P. Morgan, Allen & Company and BofA Securities as sales agents or principals. The agents may receive up to 3.0% of the gross sales price as commission. As an illustration, if 85,130,533 shares were sold at $8.81 per share, total shares outstanding could reach 1,071,651,782, compared with 986,521,249 shares outstanding as of June 30, 2026; this is a baseline figure, not the amount being offered.
Net proceeds, together with existing liquidity, are intended to fund certification and manufacturing efforts, preparation for commercial operations, working capital and general corporate purposes, and potential acquisitions and investments. Joby highlights additional potential dilution from up to 49,701,789 shares under a Toyota equity tranche, up to $45.0 million in Blade equity consideration, and approximately $50.0 million of stock at $7.4752 per share for the Resonant Sciences acquisition. The company has incurred net operating losses since inception and does not expect to pay dividends in the foreseeable future.
Joby Aviation is offering $600,000,000 of 0.75% convertible senior notes due 2032, with underwriters able to buy up to an additional $90,000,000. The notes pay 0.75% interest semi-annually and may be converted into cash, JOBY shares, or a combination at the company’s election.
The initial conversion rate is 70.4846 shares per $1,000 principal (about $14.19 per share), subject to adjustment and potential increases after certain “make-whole fundamental changes.” Joby expects net proceeds of about $582.9 million, part of a broader capital raise that includes a concurrent common stock offering and capped call transactions intended to limit dilution.
Joby Aviation is conducting a primary offering of 52,863,437 shares of common stock at $11.35 per share, raising estimated net proceeds of about $576.0 million. A 30‑day over‑allotment option allows underwriters to buy up to 7,929,515 additional shares.
Separately, Morgan Stanley, as delta underwriter, will sell 5,286,343 borrowed shares at $11.35 in a concurrent delta offering to hedge investors buying Joby’s new 0.75% convertible senior notes due 2032 in a $600,000,000 concurrent notes offering. Joby will not receive proceeds from the delta shares and will issue no new stock for that leg.
Joby expects to use the primary equity proceeds, together with existing liquidity, to fund FAA certification, manufacturing build‑out, commercial launch preparations and general corporate purposes. As of December 31, 2025, Joby preliminarily expects cash, cash equivalents and short‑term investments of approximately $1,407.9 million, highlighting a substantial capital base to support its eVTOL growth plan.
Joby Aviation, Inc. is launching an offering of convertible senior notes due 2032 alongside a concurrent common stock sale, with the offerings together anticipated to raise $1,000,000,000. The company also plans capped call transactions to limit dilution from future note conversions.
Joby reports preliminary cash, cash equivalents and short-term investments of $1,407.9 million as of December 31, 2025, to support certification, manufacturing and preparation for commercial eVTOL operations. The notes are senior unsecured, convertible into JOBY common stock under specified price and trading conditions, and may be redeemed by Joby or repurchased after certain fundamental changes.
Joby Aviation, Inc. plans a primary common stock offering alongside a concurrent offering of convertible senior notes due 2032, with aggregate proceeds from the offerings anticipated to be $1,000,000,000. A separate concurrent delta offering, run by Morgan Stanley, will involve borrowed shares to hedge certain investors in the notes and will not provide proceeds to Joby.
Joby develops piloted, all‑electric vertical take-off and landing aircraft targeting urban air taxi service, aiming to carry first passengers in 2026. As of December 31, 2025, it preliminarily expects about $1,407.9 million of cash, cash equivalents and short-term investments, and had an accumulated deficit of $2.7 billion as of September 30, 2025.
The company expects to use equity proceeds, together with existing liquidity, to fund FAA certification, manufacturing, preparation for commercial operations and general corporate purposes. The filing highlights potential dilution from this offering, future equity issuances, the Toyota and Blade transactions, and any shares issuable upon conversion of the new convertible notes, as well as stock price pressure from hedging and short-selling activity linked to the notes and capped call transactions.